Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Potrero Medical announces Sandra Morgan to join Advisory Board | |||||||||||||||||
By: PR Newswire Association LLC. - 31 May 2023 | Back to overview list |
||||||||||||||||
HAYWARD, Calif., May 31, 2023 /PRNewswire/ -- Potrero Medical, innovator of the Accuryn Monitoring System, announced today that Sandra Morgan has joined their advisory board effective immediately. Morgan served as an executive at HCA Healthcare, one of the nation's leading providers of healthcare services, for 13 years, before retiring on June 1, 2021. Before joining HCA Healthcare, Sandra worked extensively in the pharmaceutical industry for 19 years. "I see so much opportunity for Potrero to impact patient care and hospital budgets…" Sandra Morgan "We are excited to welcome Sandra to our advisory board. Her extensive experience and track record of building organizations with record-high physician engagement and growth will be instrumental in advancing our mission of improving patient outcomes of critically ill patients," said Joe Urban, CEO of Potrero Medical. Morgan added, "I am thrilled to join Potrero Medical's advisory board. I see so much opportunity for Potrero to impact patient care and hospital operating budgets with the Accuryn System, which enables early recognition of oliguric acute kidney injury (AKI) in a technology specifically designed to reduce the risk of catheter associated urinary tract infection (CAUTI). There is a real opportunity before us to transform the standard of care." About Potrero Medical
View original content to download multimedia:https://www.prnewswire.com/news-releases/potrero-medical-announces-sandra-morgan-to-join-advisory-board-301833947.html SOURCE Potrero Medical, Inc. |
|||||||||||||||||
|
|||||||||||||||||
Copyright 2023 PR Newswire Association LLC. | Back to overview list |